Glutaredoxin, a redox regulator, and its encoding gene GLRX were shown to be specifically expressed in macrophage M0, interferes with immune checkpoint function and inflammatory response in glioma, corresponding to worse survival in patients74. Here, GLRX is linked to central nervous system cancer.